CSNpharm
Pomalidomide-PEG4-C2-Amine is a PROTAC block consist of Pomalidomide and a linker with an amine functional group for conjugation reactions.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
CSNpharm
Posaconazole is a broad-spectrum triazole antifungi, it inhibits the growth of fungi by inhibiting the lanosterol 14α-demethylase enzyme, which results in a disruption the synthesis of ergosterol, a key sterol necessary for fungal cell membrane integrity and for the function of certain membrane-bound proteins.
More Information
Supplier Page
CSNpharm
Posaconazole is a broad-spectrum triazole antifungi, it inhibits the growth of fungi by inhibiting the lanosterol 14α-demethylase enzyme, which results in a disruption the synthesis of ergosterol, a key sterol necessary for fungal cell membrane integrity and for the function of certain membrane-bound proteins.
More Information
Supplier Page
CSNpharm
Posaconazole is a broad-spectrum triazole antifungi, it inhibits the growth of fungi by inhibiting the lanosterol 14α-demethylase enzyme, which results in a disruption the synthesis of ergosterol, a key sterol necessary for fungal cell membrane integrity and for the function of certain membrane-bound proteins.
More Information
Supplier Page
CSNpharm
Posaconazole is a broad-spectrum triazole antifungi, it inhibits the growth of fungi by inhibiting the lanosterol 14α-demethylase enzyme, which results in a disruption the synthesis of ergosterol, a key sterol necessary for fungal cell membrane integrity and for the function of certain membrane-bound proteins.
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Oxonic Acid Potassium Salt is an inhibitor of uricase thus inhibits uric acid metabolism. It is used to induce hyperuricemia in mice of rats.
More Information
Supplier Page
CSNpharm
PP1
100mg
| ≥98%
CSNpharm
PP1
5mg
| ≥98%
CSNpharm
PP1
50mg
| ≥98%
CSNpharm
PP1
1mg
| ≥98%
CSNpharm
PP1
10mg
| ≥98%
CSNpharm
PP121
50mg
| ≥98%
CSNpharm
PP-121 is a multi-targeted inhibitor of PDGFR, Hck, mTOR, VEGFR2, Src and Abl with IC50 of 2 nM, 8 nM, 10 nM, 12 nM, 14 nM and 18 nM, also inhibits DNA-PK with IC50 of 60 nM.
More Information
Supplier Page
PP121
5mg
| ≥98%
CSNpharm
PP-121 is a multi-targeted inhibitor of PDGFR, Hck, mTOR, VEGFR2, Src and Abl with IC50 of 2 nM, 8 nM, 10 nM, 12 nM, 14 nM and 18 nM, also inhibits DNA-PK with IC50 of 60 nM.
More Information
Supplier Page
PP121
100mg
| ≥98%
CSNpharm
PP-121 is a multi-targeted inhibitor of PDGFR, Hck, mTOR, VEGFR2, Src and Abl with IC50 of 2 nM, 8 nM, 10 nM, 12 nM, 14 nM and 18 nM, also inhibits DNA-PK with IC50 of 60 nM.
More Information
Supplier Page
PP121
10mg
| ≥98%
CSNpharm
PP-121 is a multi-targeted inhibitor of PDGFR, Hck, mTOR, VEGFR2, Src and Abl with IC50 of 2 nM, 8 nM, 10 nM, 12 nM, 14 nM and 18 nM, also inhibits DNA-PK with IC50 of 60 nM.
More Information
Supplier Page
PP2
10mg
| ≥99%
CSNpharm
PP2 is a ATP-competitive inhibitor of the Src family of protein tyrosine kinases. The IC50s for p56lck, p59fynT, Hck, Src are 4 nM, 5 nM, 5 nM, 100 nM, respectively.
More Information
Supplier Page
PP2
5mg
| ≥99%
CSNpharm
PP2 is a ATP-competitive inhibitor of the Src family of protein tyrosine kinases. The IC50s for p56lck, p59fynT, Hck, Src are 4 nM, 5 nM, 5 nM, 100 nM, respectively.
More Information
Supplier Page
PP2
100mg
| ≥99%
CSNpharm
PP2 is a ATP-competitive inhibitor of the Src family of protein tyrosine kinases. The IC50s for p56lck, p59fynT, Hck, Src are 4 nM, 5 nM, 5 nM, 100 nM, respectively.
More Information
Supplier Page
PP2
1mg
| ≥99%
CSNpharm
PP2 is a ATP-competitive inhibitor of the Src family of protein tyrosine kinases. The IC50s for p56lck, p59fynT, Hck, Src are 4 nM, 5 nM, 5 nM, 100 nM, respectively.
More Information
Supplier Page
PP2
50mg
| ≥99%
CSNpharm
PP2 is a ATP-competitive inhibitor of the Src family of protein tyrosine kinases. The IC50s for p56lck, p59fynT, Hck, Src are 4 nM, 5 nM, 5 nM, 100 nM, respectively.
More Information
Supplier Page
CSNpharm
PPQ-102 is a potent and voltage-independent CFTR inhibitor, which completely inhibit CFTR chloride current with IC50 approximately 90 nM.
More Information
Supplier Page
CSNpharm
PPQ-102 is a potent and voltage-independent CFTR inhibitor, which completely inhibit CFTR chloride current with IC50 approximately 90 nM.
More Information
Supplier Page
CSNpharm
PPQ-102 is a potent and voltage-independent CFTR inhibitor, which completely inhibit CFTR chloride current with IC50 approximately 90 nM.
More Information
Supplier Page
CSNpharm
PPQ-102 is a potent and voltage-independent CFTR inhibitor, which completely inhibit CFTR chloride current with IC50 approximately 90 nM.
More Information
Supplier Page
CSNpharm
PPQ-102 is a potent and voltage-independent CFTR inhibitor, which completely inhibit CFTR chloride current with IC50 approximately 90 nM.
More Information
Supplier Page
CSNpharm
PPQ-102 is a potent and voltage-independent CFTR inhibitor, which completely inhibit CFTR chloride current with IC50 approximately 90 nM.
More Information
Supplier Page
PQ401
10mg
| ≥99%
CSNpharm
PQ401, a selective insulin-like growth factor-1 receptor blocker, is a diarylurea compound that inhibits IGF1R autophosphorylation with IC50 < 1 μM.
More Information
Supplier Page
PQ401
50mg
| ≥99%
CSNpharm
PQ401, a selective insulin-like growth factor-1 receptor blocker, is a diarylurea compound that inhibits IGF1R autophosphorylation with IC50 < 1 μM.
More Information
Supplier Page
PQ401
5mg
| ≥99%
CSNpharm
PQ401, a selective insulin-like growth factor-1 receptor blocker, is a diarylurea compound that inhibits IGF1R autophosphorylation with IC50 < 1 μM.
More Information
Supplier Page
PQ401
1mg
| ≥99%
CSNpharm
PQ401, a selective insulin-like growth factor-1 receptor blocker, is a diarylurea compound that inhibits IGF1R autophosphorylation with IC50 < 1 μM.
More Information
Supplier Page
CSNpharm
PR-619 is a broad-spectrum and reversible inhibitor of the deubiquitinylating enzymes (DUBs) with EC50 of 1-20 μM and it was developed for chemotherapy.
More Information
Supplier Page
CSNpharm
PR-619 is a broad-spectrum and reversible inhibitor of the deubiquitinylating enzymes (DUBs) with EC50 of 1-20 μM and it was developed for chemotherapy.
More Information
Supplier Page
CSNpharm
PR-619 is a broad-spectrum and reversible inhibitor of the deubiquitinylating enzymes (DUBs) with EC50 of 1-20 μM and it was developed for chemotherapy.
More Information
Supplier Page
CSNpharm
Praeruptorin D, a natural product isolated and purified from the roots of Peucedanum praeruptorum Dunn., can significantly inhibit the infiltration of activated polymorphonuclear leukocytes (PMNs) and decrease the levels of TNF-α and IL-6 in bronchoalveolar lavage fluid at the same dose, suppresses LPS induced Nuclear Factor-kappa B (NF-κB) pathway activation in the lung by decreasing […]
More Information
Supplier Page
CSNpharm
Praeruptorin D, a natural product isolated and purified from the roots of Peucedanum praeruptorum Dunn., can significantly inhibit the infiltration of activated polymorphonuclear leukocytes (PMNs) and decrease the levels of TNF-α and IL-6 in bronchoalveolar lavage fluid at the same dose, suppresses LPS induced Nuclear Factor-kappa B (NF-κB) pathway activation in the lung by decreasing […]
More Information
Supplier Page
CSNpharm
CSNpharm
CSNpharm
Pramipexole is an agonist of dopamine receptors D2, D3, and D4 (Ki = 3.9, 2.2, 0.5, and 5.1 nM respectively) and it is indicated for treating Parkinson’s disease (PD) and restless legs syndrome (RLS).
More Information
Supplier Page
CSNpharm
Pramipexole is an agonist of dopamine receptors D2, D3, and D4 (Ki = 3.9, 2.2, 0.5, and 5.1 nM respectively) and it is indicated for treating Parkinson’s disease (PD) and restless legs syndrome (RLS).
More Information
Supplier Page
